Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2018 | Immunotherapy in NSCLC: a perspective

Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Giorgio Scagliotti, MD, PhD, from the University of Turin, Turin, Italy, provides an overview of recent trial data concerning the immunotherapy of non-oncogene addicted non-small cell lung cancer (NSCLC). Dr Scagliotti emphasizes the importance of exploring combinations of immunotherapy and other treatment modalities in a clinical setting.